Last Updated 29 June 2022.
This vaccine is approved.
Approved in 111 countries
24 trials in 24 countries
Approval Source: maserumetro.com
Non Replicating Viral Vector
Approved in 140 countries
65 trials in 31 countries
Approval Source: allafrica.com
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form